Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1990-6-25
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0022-3999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
339-41
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1692880-Amniocentesis,
pubmed-meshheading:1692880-Anxiety,
pubmed-meshheading:1692880-Female,
pubmed-meshheading:1692880-Humans,
pubmed-meshheading:1692880-Infant, Newborn,
pubmed-meshheading:1692880-Pregnancy,
pubmed-meshheading:1692880-Prenatal Diagnosis,
pubmed-meshheading:1692880-Risk Factors,
pubmed-meshheading:1692880-alpha-Fetoproteins
|
pubmed:year |
1990
|
pubmed:articleTitle |
Impact of prenatal screening of maternal serum alpha-fetoprotein (MSAFP) and diagnostic testing.
|
pubmed:publicationType |
Letter,
Comment
|